4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-058890
Chief Financial Officer sold 3,500 shares at $14.30 ($50,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-11-25 | Sale | −3,500 | $14.30 | $50,050 | 83,132 | D |
| Open-market sales · 3,500 sh · avg $14.30 · $50,050 | |||||||
Loading xslF345X03/doc4.xml…